the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Jul 12, 2026-1dpatentBelrapzobendamustine hydrochlorideEagle Pharmaceuticals Inc
- Jul 13, 20260dpatentGilotrifafatinib dimaleateBoehringer Ingelheim Corp
- Jul 13, 20260dRTOOpillnorgestrelHRA Pharma LLC
- Jul 13, 20260dM-301Vekluryremdesivir$GILDGILEAD SCIENCES, INC.
- Jul 14, 20261dCGTInveltysloteprednol etabonate$ALCALCON INC
- Jul 16, 20263dNCERezurockbelumosudil mesylateKadmon Pharmaceuticals LLC
- Jul 16, 20263dNCEFexinidazolefexinidazoleSanofi-Aventis US LLC
- Jul 17, 20264dpatentDexlansoprazoledexlansoprazoleTWi Pharmaceuticals USA Inc
- Jul 18, 20265dpatentNILOTINIB HYDROCHLORIDENILOTINIB HYDROCHLORIDEHetero Labs Ltd
- Jul 18, 20265dpatentPepcidfamotidine$KVUEKenvue Inc.
- Jul 19, 20266dpatentJelmytomitomycin$URGNUroGen Pharma Ltd.
- Jul 19, 20266dpatentSpiriva Handihalertiotropium bromideBoehringer Ingelheim Corp
- Jul 19, 20266dM-299ApremilastapremilastAnnora Pharma Pvt Ltd
- Jul 20, 20267dpatentKyproliscarfilzomib$AMGNAMGEN INC
- Jul 20, 20267dNCEBylvayodevixibatIpsen SA
- Jul 20, 20267dpatentTemsirolimustemsirolimusAccord Healthcare Inc
- Jul 21, 20268dD-190WegovysemaglutideNovo Nordisk Inc
- Jul 24, 202611dpatentLidocaine Hydrochloridelidocaine hydrochlorideInternational Medication Systems Ltd
- Jul 26, 202613dCGTIOHEXOLIOHEXOL$AMRXAmneal Pharmaceuticals, Inc.
- Jul 26, 202613dpatentOngentysopicapone [INN]$AMRXAmneal Pharmaceuticals, Inc.
- Jul 27, 202614dM-300Kazano(alogliptin benzoate + metformin hydrochloride)Takeda Pharmaceuticals USA Inc
- Jul 27, 202614dM-300Alogliptin Benzoate Perrigoalogliptin benzoatePerrigo New York Inc
- Jul 27, 202614dCGTMycapssaoctreotide acetateChiasma Inc
- Jul 27, 202614dpatentSugammadex Sodiumsugammadex sodiumB. Braun Medical Inc
- Jul 28, 202615dpatentAbilify MaintenaaripiprazoleOtsuka America Pharmaceutical Inc
- Jul 30, 202617dpatentOrenitramtreprostinil diolamine$UTHRUNITED THERAPEUTICS Corp
- Jul 31, 202618dpatentSUMATRIPTAN SUCCINATESUMATRIPTAN SUCCINATEAllergan USA Inc
- Jul 31, 202618dpatentSublocadebuprenorphine [INN]$INDVIndivior Pharmaceuticals, Inc.
- Jul 31, 202618dpatentMetformin Hydrochloridemetformin hydrochlorideIntellipharmaceutics Ltd
- Aug 2, 202620dpatentBalsalazide Disodiumbalsalazide disodiumCarnegie Pharmaceuticals LLC
- Aug 2, 202620dD-189PrevymisletermovirMerck Sharp & Dohme Corp (Inactive)
- Aug 2, 202620dODE*Turaliopexidartinib hydrochlorideDaiichi Sankyo Co Ltd
- Aug 2, 202620dpatentLivdelziseladelpar lysineCymaBay Therapeutics Inc
- Aug 2, 202620dpatentZelborafvemurafenibF. Hoffmann-La Roche Ltd
- Aug 4, 202622dpatentBrisdelleparoxetine mesylateLegacy Pharma Solutions
- Aug 6, 202624dpatentBaxdeladelafloxacin meglumineMelinta Therapeutics LLC
- Aug 9, 202627dM-306Sirturobedaquiline fumarateJanssen Therapeutics
- Aug 10, 202628dpatentBeleodaqbelinostatAcrotech Biopharma Inc
- Aug 11, 202629dI-980Akeega(abiraterone acetate + niraparib)$JNJJOHNSON & JOHNSON
- Aug 11, 202629dpatentOsphenaospemifeneDuchesnay USA Inc
- Aug 13, 202631dpatentNuedexta(dextromethorphan [INN] + quinidine sulfate)Otsuka America Pharmaceutical Inc
- Aug 13, 202631dI-931Weliregbelzutifan$MRKMerck & Co., Inc.
- Aug 13, 202631dpatentAbraxanepaclitaxelCelgene Corp
- Aug 14, 202632dpatentCometriqcabozantinib s-malate$EXELEXELIXIS, INC.
- Aug 14, 202632dpatentMalathionSuven Life Sciences Ltd
- Aug 14, 202632dNPMelblezmelphalan hydrochloride$DCTHDELCATH SYSTEMS, INC.
- Aug 14, 202632dNPPWakixpitolisant hydrochloride$HRMYHarmony Biosciences Holdings, Inc.
- Aug 14, 202632dGAINPretomanidpretomanidMylan Specialty LP
- Aug 15, 202633dNPRozlytrekentrectinibF. Hoffmann-La Roche Ltd
- Aug 16, 202634dpatentGLYCOPYRROLATEGLYCOPYRROLATEExela Pharma Sciences LLC
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)